Skip to content
Citation only via OpenAlex

Current Pharmacotherapy for Alzheimer's Disease

Alberto Lleó, Steven Mark Greenberg, John H. Growdon

Annual Review of Medicine · 2005 · ▲ 345 citations

Abstract

Alzheimer's disease (AD) is an age-related neurodegenerative disease that affects approximately 4.5 million people in the United States. The mainstays of current pharmacotherapy for AD are compounds aimed at increasing the levels of acetylcholine in the brain, thereby facilitating cholinergic neurotransmission through inhibition of the cholinesterases. These drugs, known as acetylcholinesterase inhibitors (AChEIs), were first approved by the U.S. Food and Drug Administration (FDA) in 1995 based on clinical trials showing modest symptomatic benefit on cognitive, behavioral, and global measures. In 2004 the FDA approved memantine, an NMDA antagonist, for treating dementia symptoms in moderate to severe AD cases. In clinical practice, memantine may be co-administered with an AChEI, although neither drug individually or in combination affects the underlying pathophysiology of dementia. Dementia in AD results from progressive synaptic loss and neuronal death. As knowledge of the mechanisms responsible for neurodegeneration in AD increases, it is anticipated that neuroprotective drugs to slow or prevent neuronal dysfunction and death will be developed to complement current symptomatic treatments.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1146/annurev.med.57.121304.131442
Canonical
link ↗
Fetched
2026-10-16 MST

Cite this

APA
Lleó, A., Greenberg, S.M., &amp; Growdon, J.H. (2005). Current Pharmacotherapy for Alzheimer's Disease. <em>Annual Review of Medicine</em>. https://doi.org/10.1146/annurev.med.57.121304.131442
Vancouver
Lleó A, Greenberg SM, Growdon JH. Current Pharmacotherapy for Alzheimer's Disease. Annual Review of Medicine. 2005. doi:10.1146/annurev.med.57.121304.131442.
BibTeX
@article{alberto2005Curren, title = {Current Pharmacotherapy for Alzheimer's Disease}, author = {Alberto Lleó and Steven Mark Greenberg and John H. Growdon}, journal = {Annual Review of Medicine}, year = {2005}, doi = {10.1146/annurev.med.57.121304.131442}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings